company

BillionToOne

BillionToOne is a precision diagnostics company based in Menlo Park, California. It makes molecular tests focused on prenatal screening and liquid biopsy.

billiontoone.com

Key facts

Founded: 2016source
Based in: Menlo Park, Californiasource
Key event: Appointed Ross Taylor as chief financial officer on February 21, 2024source
Mission: Create powerful and accurate tests that are accessible to allsource
Platform: Quantitative Counting Technology (QCT) molecular counting platformsource

WYDE coverage of BillionToOne

WYDE Newsroom has published one article about BillionToOne, on Jun 30, 2026. BillionToOne is the subject of 1 story. The most recent is A BillionToOne Blood Test Beat Standard Scans at Predicting Cancer Survival.

Healthcare

A BillionToOne Blood Test Beat Standard Scans at Predicting Cancer Survival

In a peer-reviewed study of 142 patients across 12 tumor types, the Northstar Response test tracked immunotherapy outcomes more accurately than standard-of-care imaging

Jun 30, 2026 · 2 min read · Subject of the story

Sources

Track the institutions that move money.

Data-driven coverage, every week.